Annual EPS
-$1.30
-$0.52-66.67%
31 December 2023
Summary:
Zevra Therapeutics annual earnings per share is currently -$1.30, with the most recent change of -$0.52 (-66.67%) on 31 December 2023. During the last 3 years, it has risen by +$1.91 (+59.50%). ZVRA annual EPS is now -66.67% below its all-time high of -$0.78, reached on 31 December 2022.ZVRA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.69
-$0.21-43.75%
30 September 2024
Summary:
Zevra Therapeutics quarterly earnings per share is currently -$0.69, with the most recent change of -$0.21 (-43.75%) on 30 September 2024. Over the past year, it has dropped by -$0.39 (-130.00%). ZVRA quarterly EPS is now -107.44% below its all-time high of $9.28, reached on 01 June 2016.ZVRA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$2.11
-$0.39-22.67%
30 September 2024
Summary:
Zevra Therapeutics TTM earnings per share is currently -$2.11, with the most recent change of -$0.39 (-22.67%) on 30 September 2024. Over the past year, it has dropped by -$1.51 (-251.67%). ZVRA TTM EPS is now -368.89% below its all-time high of -$0.45, reached on 01 March 2022.ZVRA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA EPS Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -66.7% | -130.0% | -251.7% |
3 y3 years | +59.5% | -1280.0% | +48.2% |
5 y5 years | +97.4% | -171.9% | +76.0% |
ZVRA EPS High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -66.7% | +59.5% | -531.3% | +1.4% | -368.9% | +48.2% |
5 y | 5 years | -66.7% | +97.4% | -171.9% | +75.6% | -368.9% | +85.5% |
alltime | all time | -66.7% | +98.9% | -107.4% | +98.2% | -368.9% | +97.3% |
Zevra Therapeutics EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$0.69(+43.8%) | -$2.11(+22.7%) |
June 2024 | - | -$0.48(+20.0%) | -$1.72(+30.3%) |
Mar 2024 | - | -$0.40(-25.9%) | -$1.32(+1.5%) |
Dec 2023 | -$1.30(+66.7%) | -$0.54(+80.0%) | -$1.30(+116.7%) |
Sept 2023 | - | -$0.30(+275.0%) | -$0.60(+22.4%) |
June 2023 | - | -$0.08(-78.9%) | -$0.49(-55.9%) |
Mar 2023 | - | -$0.38(-337.5%) | -$1.11(+42.3%) |
Dec 2022 | -$0.78(-63.0%) | $0.16(-184.2%) | -$0.78(-12.4%) |
Sept 2022 | - | -$0.19(-72.9%) | -$0.89(+18.7%) |
June 2022 | - | -$0.70(+1300.0%) | -$0.75(+66.7%) |
Mar 2022 | - | -$0.05(-200.0%) | -$0.45(-84.4%) |
Dec 2021 | -$2.11(-34.3%) | - | - |
Dec 2021 | - | $0.05(-200.0%) | -$2.89(-29.0%) |
Sept 2021 | - | -$0.05(-87.5%) | -$4.07(-13.4%) |
June 2021 | - | -$0.40(-83.9%) | -$4.70(+14.9%) |
Mar 2021 | - | -$2.49(+120.4%) | -$4.09(+16.2%) |
Dec 2020 | -$3.21(-75.7%) | -$1.13(+66.2%) | -$3.52(-32.6%) |
Sept 2020 | - | -$0.68(-423.8%) | -$5.22(+45.8%) |
June 2020 | - | $0.21(-110.9%) | -$3.58(-60.5%) |
Mar 2020 | - | -$1.92(-32.2%) | -$9.07(-37.5%) |
Dec 2019 | -$13.23 | -$2.83(-394.8%) | -$14.51(+64.9%) |
Sept 2019 | - | $0.96(-118.2%) | -$8.80(-64.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2019 | - | -$5.28(-28.3%) | -$24.80(-27.2%) |
Mar 2019 | - | -$7.36(-355.6%) | -$34.08(-38.1%) |
Dec 2018 | -$50.40(+6.4%) | $2.88(-119.1%) | -$55.04(-20.7%) |
Sept 2018 | - | -$15.04(+3.3%) | -$69.44(+6.4%) |
June 2018 | - | -$14.56(-48.6%) | -$65.28(+13.0%) |
Mar 2018 | - | -$28.32(+145.8%) | -$57.76(+22.4%) |
Dec 2017 | -$47.36(+161.9%) | -$11.52(+5.9%) | -$47.20(+1.4%) |
Sept 2017 | - | -$10.88(+54.5%) | -$46.56(-7.6%) |
June 2017 | - | -$7.04(-60.4%) | -$50.40(+47.9%) |
Mar 2017 | - | -$17.76(+63.2%) | -$34.08(+74.6%) |
Dec 2016 | -$18.08(-84.8%) | -$10.88(-26.1%) | -$19.52(+3.4%) |
Sept 2016 | - | -$14.72(-258.6%) | -$18.88(+25.5%) |
June 2016 | - | $9.28(-390.0%) | -$15.04(-76.3%) |
Mar 2016 | - | -$3.20(-68.8%) | -$63.52(-6.7%) |
Dec 2015 | -$118.72(+273.4%) | -$10.24(-5.9%) | -$68.09(-7.0%) |
Sept 2015 | - | -$10.88(-72.2%) | -$73.24(-4.8%) |
June 2015 | - | -$39.20(+404.8%) | -$76.95(+70.8%) |
Mar 2015 | - | -$7.77(-49.5%) | -$45.06(+9.4%) |
Dec 2014 | -$31.79(+197.4%) | -$15.39(+5.5%) | -$41.19(+59.7%) |
Sept 2014 | - | -$14.60(+99.8%) | -$25.80(+130.3%) |
June 2014 | - | -$7.31(+87.5%) | -$11.20(+187.5%) |
Mar 2014 | - | -$3.90 | -$3.90 |
Dec 2013 | -$10.69 | - | - |
FAQ
- What is Zevra Therapeutics annual earnings per share?
- What is the all time high annual EPS for Zevra Therapeutics?
- What is Zevra Therapeutics annual EPS year-on-year change?
- What is Zevra Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly EPS year-on-year change?
- What is Zevra Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Zevra Therapeutics?
- What is Zevra Therapeutics TTM EPS year-on-year change?
What is Zevra Therapeutics annual earnings per share?
The current annual EPS of ZVRA is -$1.30
What is the all time high annual EPS for Zevra Therapeutics?
Zevra Therapeutics all-time high annual earnings per share is -$0.78
What is Zevra Therapeutics annual EPS year-on-year change?
Over the past year, ZVRA annual earnings per share has changed by -$0.52 (-66.67%)
What is Zevra Therapeutics quarterly earnings per share?
The current quarterly EPS of ZVRA is -$0.69
What is the all time high quarterly EPS for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly earnings per share is $9.28
What is Zevra Therapeutics quarterly EPS year-on-year change?
Over the past year, ZVRA quarterly earnings per share has changed by -$0.39 (-130.00%)
What is Zevra Therapeutics TTM earnings per share?
The current TTM EPS of ZVRA is -$2.11
What is the all time high TTM EPS for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM earnings per share is -$0.45
What is Zevra Therapeutics TTM EPS year-on-year change?
Over the past year, ZVRA TTM earnings per share has changed by -$1.51 (-251.67%)